Drug Pipeline

Daridorexant 50 mg Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
4
Recruiting
7
Top Sponsors
Active Studies by Phase
Phase 4
5
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07267559 Dual Orexin Antagonism and Emotion and Affective Processing Study Learning Recruiting
NCT05924425 Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to… Alzheimer Disease Recruiting
NCT07136415 Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia… Menopausal Women Recruiting
NCT07328594 Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking Smoking Not Yet Recruiting
NCT07555743 Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and… Insomnia Not Yet Recruiting
Phase 2
NCT07217912 Daridorexant to Prevent Post-cardiotomy Delirium Postoperative Cognitive Decline Recruiting
NCT07532252 Daridorexant for Alcohol Use Disorder Alcohol Use Disorder Not Yet Recruiting
Sponsors Running Daridorexant 50 mg Trials
University Hospital, Montpellier (1) Brigham and Women's Hospital (1) University of Rochester (1) University of Oxford (1) Legacy Health System (1) Johns Hopkins University (1) Institut d'Investigació Biomèdica de Bellvitge (1)
Disease Areas
Alzheimer's Disease (1) Depression (1)
Get alerts when Daridorexant 50 mg trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free